ID   M3K4_HUMAN              Reviewed;        1608 AA.
AC   Q9Y6R4; Q5VTT8; Q5VTT9; Q92612; Q9H408;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   05-OCT-2010, entry version 102.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 4;
DE            EC=2.7.11.25;
DE   AltName: Full=MAP three kinase 1;
DE   AltName: Full=MAPK/ERK kinase kinase 4;
DE            Short=MEK kinase 4;
DE            Short=MEKK 4;
GN   Name=MAP3K4; Synonyms=KIAA0213, MAPKKK4, MEKK4, MTK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   ALTERNATIVE SPLICING, AND MUTAGENESIS OF LYS-1372.
RC   TISSUE=Fetal liver, and Skeletal muscle;
RX   MEDLINE=97449143; PubMed=9305639; DOI=10.1093/emboj/16.16.4973;
RA   Takekawa M., Posas F., Saito H.;
RT   "A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases,
RT   MTK1, mediates stress-induced activation of the p38 and JNK
RT   pathways.";
RL   EMBO J. 16:4973-4982(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Bone marrow;
RX   MEDLINE=97191544; PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI.
RT   The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by
RT   analysis of cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [3]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R., Nomura N.;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   FUNCTION, ENZYME REGULATION, INTERACTION WITH GADD45 AND MAP2K6, AND
RP   MUTAGENESIS OF LYS-1372.
RX   PubMed=12052864; DOI=10.1128/MCB.22.13.4544-4555.2002;
RA   Mita H., Tsutsui J., Takekawa M., Witten E.A., Saito H.;
RT   "Regulation of MTK1/MEKK4 kinase activity by its N-terminal
RT   autoinhibitory domain and GADD45 binding.";
RL   Mol. Cell. Biol. 22:4544-4555(2002).
RN   [6]
RP   INTERACTION WITH AXIN1 AND DIXDC1.
RX   PubMed=15262978; DOI=10.1074/jbc.M404598200;
RA   Wong C.K., Luo W., Deng Y., Zou H., Ye Z., Lin S.-C.;
RT   "The DIX domain protein coiled-coil-DIX1 inhibits c-Jun N-terminal
RT   kinase activation by Axin and dishevelled through distinct
RT   mechanisms.";
RL   J. Biol. Chem. 279:39366-39373(2004).
RN   [7]
RP   INTERACTION WITH TRAF4.
RX   PubMed=16157600; DOI=10.1074/jbc.C500260200;
RA   Abell A.N., Johnson G.L.;
RT   "MEKK4 is an effector of the embryonic TRAF4 for JNK activation.";
RL   J. Biol. Chem. 280:35793-35796(2005).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-447, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-294; ILE-335; HIS-566; HIS-584;
RP   PRO-906; GLN-1413 AND VAL-1492.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Component of a protein kinase signal transduction
CC       cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not
CC       the ERK pathway. Specifically phosphorylates and activates MAP2K4
CC       and MAP2K6.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: N-terminal autoinhibitory domain interacts with
CC       the C-terminal kinase domain, inhibiting kinase activity, and
CC       preventing interaction with its substrate, MAP2K6. The GADD45
CC       proteins activate the kinase by binding to the N-terminal domain.
CC       Activated by phosphorylation on Thr-1505.
CC   -!- SUBUNIT: Monomer and homodimer. Homodimerization enhances kinase
CC       activity. Interacts with TRAF4; this promotes homodimerization (By
CC       similarity). Binds both upstream activators and downstream
CC       substrates in multimolecular complexes. Interacts with AXIN1 and
CC       DIXDC1; interaction with DIXDC1 prevents interaction with AXIN1.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region (By
CC       similarity). Note=Localized in perinuclear vesicular-like
CC       structures, probably Golgi-associated vesicles (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=A;
CC         IsoId=Q9Y6R4-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=Q9Y6R4-2; Sequence=VSP_004884;
CC       Name=3;
CC         IsoId=Q9Y6R4-3; Sequence=VSP_039199, VSP_039200;
CC         Note=Gene prediction based on EST data;
CC       Name=4;
CC         IsoId=Q9Y6R4-4; Sequence=VSP_004884, VSP_039200;
CC         Note=Gene prediction based on EST data;
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in heart, placenta,
CC       skeletal muscle and pancreas, and at lower levels in other
CC       tissues.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA13204.2; Type=Erroneous initiation; Note=Translation N-terminally shortened;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF002715; AAB68804.1; -; mRNA.
DR   EMBL; D86968; BAA13204.2; ALT_INIT; mRNA.
DR   EMBL; AL109942; CAC12766.2; -; Genomic_DNA.
DR   EMBL; AL139393; CAC12766.2; JOINED; Genomic_DNA.
DR   EMBL; AL591045; CAC12766.2; JOINED; Genomic_DNA.
DR   EMBL; AL596452; CAC12766.2; JOINED; Genomic_DNA.
DR   EMBL; AL109942; CAI21477.1; -; Genomic_DNA.
DR   EMBL; AL139393; CAI21477.1; JOINED; Genomic_DNA.
DR   EMBL; AL591045; CAI21477.1; JOINED; Genomic_DNA.
DR   EMBL; AL596452; CAI21477.1; JOINED; Genomic_DNA.
DR   EMBL; AL139393; CAI20815.1; -; Genomic_DNA.
DR   EMBL; AL109942; CAI20815.1; JOINED; Genomic_DNA.
DR   EMBL; AL591045; CAI20815.1; JOINED; Genomic_DNA.
DR   EMBL; AL596452; CAI20815.1; JOINED; Genomic_DNA.
DR   EMBL; AL139393; CAI20816.1; -; Genomic_DNA.
DR   EMBL; AL109942; CAI20816.1; JOINED; Genomic_DNA.
DR   EMBL; AL591045; CAI20816.1; JOINED; Genomic_DNA.
DR   EMBL; AL596452; CAI20816.1; JOINED; Genomic_DNA.
DR   EMBL; AL591045; CAH70639.1; -; Genomic_DNA.
DR   EMBL; AL109942; CAH70639.1; JOINED; Genomic_DNA.
DR   EMBL; AL139393; CAH70639.1; JOINED; Genomic_DNA.
DR   EMBL; AL596452; CAH70639.1; JOINED; Genomic_DNA.
DR   EMBL; AL591045; CAH70640.1; -; Genomic_DNA.
DR   EMBL; AL109942; CAH70640.1; JOINED; Genomic_DNA.
DR   EMBL; AL139393; CAH70640.1; JOINED; Genomic_DNA.
DR   EMBL; AL596452; CAH70640.1; JOINED; Genomic_DNA.
DR   EMBL; AL596452; CAI41309.1; -; Genomic_DNA.
DR   EMBL; AL109942; CAI41309.1; JOINED; Genomic_DNA.
DR   EMBL; AL139393; CAI41309.1; JOINED; Genomic_DNA.
DR   EMBL; AL591045; CAI41309.1; JOINED; Genomic_DNA.
DR   EMBL; AL596452; CAI41310.1; -; Genomic_DNA.
DR   EMBL; AL109942; CAI41310.1; JOINED; Genomic_DNA.
DR   EMBL; AL139393; CAI41310.1; JOINED; Genomic_DNA.
DR   EMBL; AL591045; CAI41310.1; JOINED; Genomic_DNA.
DR   IPI; IPI00186536; -.
DR   IPI; IPI00386260; -.
DR   IPI; IPI00873480; -.
DR   IPI; IPI00964387; -.
DR   PIR; T03022; T03022.
DR   RefSeq; NP_005913.2; -.
DR   RefSeq; NP_006715.2; -.
DR   UniGene; Hs.390428; -.
DR   ProteinModelPortal; Q9Y6R4; -.
DR   SMR; Q9Y6R4; 1310-1602.
DR   IntAct; Q9Y6R4; 9.
DR   MINT; MINT-1213156; -.
DR   STRING; Q9Y6R4; -.
DR   PhosphoSite; Q9Y6R4; -.
DR   PRIDE; Q9Y6R4; -.
DR   Ensembl; ENST00000392142; ENSP00000375986; ENSG00000085511.
DR   GeneID; 4216; -.
DR   KEGG; hsa:4216; -.
DR   UCSC; uc003qtn.1; human.
DR   UCSC; uc003qto.1; human.
DR   CTD; 4216; -.
DR   GeneCards; GC06P161412; -.
DR   H-InvDB; HIX0006350; -.
DR   HGNC; HGNC:6856; MAP3K4.
DR   HPA; HPA007625; -.
DR   MIM; 602425; gene.
DR   PharmGKB; PA30600; -.
DR   HOVERGEN; HBG006304; -.
DR   InParanoid; Q9Y6R4; -.
DR   PhylomeDB; Q9Y6R4; -.
DR   BRENDA; 2.7.11.25; 247.
DR   BRENDA; 2.7.12.2; 247.
DR   Pathway_Interaction_DB; p38_mkk3_6pathway; p38 MAPK signaling pathway.
DR   NextBio; 16627; -.
DR   ArrayExpress; Q9Y6R4; -.
DR   Bgee; Q9Y6R4; -.
DR   CleanEx; HS_MAP3K4; -.
DR   Genevestigator; Q9Y6R4; -.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0000186; P:activation of MAPKK activity; TAS:ProtInc.
DR   GO; GO:0007254; P:JNK cascade; TAS:ProtInc.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; ISS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR015747; MAPKKK4.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22986:SF60; MAPKKK4; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   1608       Mitogen-activated protein kinase kinase
FT                                kinase 4.
FT                                /FTId=PRO_0000086247.
FT   DOMAIN     1343   1601       Protein kinase.
FT   NP_BIND    1349   1357       ATP (By similarity).
FT   COMPBIAS      4      7       Poly-Ala.
FT   COMPBIAS     25     38       Poly-Pro.
FT   COMPBIAS   1190   1202       Poly-Ala.
FT   ACT_SITE   1463   1463       Proton acceptor (By similarity).
FT   BINDING    1372   1372       ATP (By similarity).
FT   MOD_RES     447    447       Phosphothreonine.
FT   MOD_RES     499    499       Phosphoserine.
FT   MOD_RES    1505   1505       Phosphothreonine (By similarity).
FT   VAR_SEQ    1139   1142       Missing (in isoform 3).
FT                                /FTId=VSP_039199.
FT   VAR_SEQ    1175   1224       Missing (in isoform 2 and isoform 4).
FT                                /FTId=VSP_004884.
FT   VAR_SEQ    1543   1602       Missing (in isoform 3 and isoform 4).
FT                                /FTId=VSP_039200.
FT   VARIANT     157    157       R -> H (in dbSNP:rs4559074).
FT                                /FTId=VAR_059767.
FT   VARIANT     294    294       I -> T (in dbSNP:rs35842248).
FT                                /FTId=VAR_040686.
FT   VARIANT     335    335       V -> I (in dbSNP:rs35730939).
FT                                /FTId=VAR_040687.
FT   VARIANT     566    566       R -> H (in dbSNP:rs55765351).
FT                                /FTId=VAR_040688.
FT   VARIANT     584    584       Q -> H (in dbSNP:rs34018542).
FT                                /FTId=VAR_040689.
FT   VARIANT     906    906       H -> P (in dbSNP:rs35533223).
FT                                /FTId=VAR_040690.
FT   VARIANT    1413   1413       E -> Q (in an ovarian serous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040691.
FT   VARIANT    1492   1492       A -> V.
FT                                /FTId=VAR_040692.
FT   MUTAGEN    1372   1372       K->R: Loss of activity.
FT   CONFLICT    791    791       R -> I (in Ref. 1; AAB68804).
FT   CONFLICT   1199   1199       Missing (in Ref. 1; AAB68804).
SQ   SEQUENCE   1608 AA;  181685 MW;  C22294914945EA91 CRC64;
     MREAAAALVP PPAFAVTPAA AMEEPPPPPP PPPPPPEPET ESEPECCLAA RQEGTLGDSA
     CKSPESDLED FSDETNTENL YGTSPPSTPR QMKRMSTKHQ RNNVGRPASR SNLKEKMNAP
     NQPPHKDTGK TVENVEEYSY KQEKKIRAAL RTTERDRKKN VQCSFMLDSV GGSLPKKSIP
     DVDLNKPYLS LGCSNAKLPV SVPMPIARPA RQTSRTDCPA DRLKFFETLR LLLKLTSVSK
     KKDREQRGQE NTSGFWLNRS NELIWLELQA WHAGRTINDQ DFFLYTARQA IPDIINEILT
     FKVDYGSFAF VRDRAGFNGT SVEGQCKATP GTKIVGYSTH HEHLQRQRVS FEQVKRIMEL
     LEYIEALYPS LQALQKDYEK YAAKDFQDRV QALCLWLNIT KDLNQKLRIM GTVLGIKNLS
     DIGWPVFEIP SPRPSKGNEP EYEGDDTEGE LKELESSTDE SEEEQISDPR VPEIRQPIDN
     SFDIQSRDCI SKKLERLESE DDSLGWGAPD WSTEAGFSRH CLTSIYRPFV DKALKQMGLR
     KLILRLHKLM DGSLQRARIA LVKNDRPVEF SEFPDPMWGS DYVQLSRTPP SSEEKCSAVS
     WEELKAMDLP SFEPAFLVLC RVLLNVIHEC LKLRLEQRPA GEPSLLSIKQ LVRECKEVLK
     GGLLMKQYYQ FMLQEVLEDL EKPDCNIDAF EEDLHKMLMV YFDYMRSWIQ MLQQLPQASH
     SLKNLLEEEW NFTKEITHYI RGGEAQAGKL FCDIAGMLLK STGSFLEFGL QESCAEFWTS
     ADDSSASDEI RRSVIEISRA LKELFHEARE RASKALGFAK MLRKDLEIAA EFRLSAPVRD
     LLDVLKSKQY VKVQIPGLEN LQMFVPDTLA EEKSIILQLL NAAAGKDCSK DSDDVLIDAY
     LLLTKHGDRA RDSEDSWGTW EAQPVKVVPQ VETVDTLRSM QVDNLLLVVM QSAHLTIQRK
     AFQQSIEGLM TLCQEQTSSQ PVIAKALQQL KNDALELCNR ISNAIDRVDH MFTSEFDAEV
     DESESVTLQQ YYREAMIQGY NFGFEYHKEV VRLMSGEFRQ KIGDKYISFA RKWMNYVLTK
     CESGRGTRPR WATQGFDFLQ AIEPAFISAL PEDDFLSLQA LMNECIGHVI GKPHSPVTGL
     YLAIHRNSPR PMKVPRCHSD PPNPHLIIPT PEGFSTRSMP SDARSHGSPA AAAAAAAAAV
     AASRPSPSGG DSVLPKSISS AHDTRGSSVP ENDRLASIAA ELQFRSLSRH SSPTEERDEP
     AYPRGDSSGS TRRSWELRTL ISQSKDTASK LGPIEAIQKS VRLFEEKRYR EMRRKNIIGQ
     VCDTPKSYDN VMHVGLRKVT FKWQRGNKIG EGQYGKVYTC ISVDTGELMA MKEIRFQPND
     HKTIKETADE LKIFEGIKHP NLVRYFGVEL HREEMYIFME YCDEGTLEEV SRLGLQEHVI
     RLYSKQITIA INVLHEHGIV HRDIKGANIF LTSSGLIKLG DFGCSVKLKN NAQTMPGEVN
     STLGTAAYMA PEVITRAKGE GHGRAADIWS LGCVVIEMVT GKRPWHEYEH NFQIMYKVGM
     GHKPPIPERL SPEGKDFLSH CLESDPKMRW TASQLLDHSF VKVCTDEE
//
